600196.SH
复星医药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.79
−3.27%Margins
Gross margin
50.5%
EBITDA margin
20.3%
EBIT margin
12.4%
Net margin
8.2%
FCF margin
2.1%
7.1%
Return on equity
2.8%
Return on assets
6.7%
Return on invested capital
0.35x
Asset turnover
CNY 5.3B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026